Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Healthy Adults × adagrasib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Colorectal Neoplasms 10 Neoplasm Metastasis 9 Neoplasms 5 Lung Neoplasms 5 Colonic Neoplasms 5 Pancreatic Neoplasms 3 Carcinoma, Renal Cell 2 Advanced Solid Tumor 2 Solid Tumors 1 Resectable Non-Small Cell Lung Cancer 1 Rectal Neoplasms 1 Kidney Neoplasms 1 Healthy Adults 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

eltrombopag 1 adagrasib 1 Peptides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05924152 2024-03-13

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Mirati Therapeutics Inc.

Phase 1 Completed

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon ⚡